Q4 2022 Holdings
Filed 2023-02-14 | 64 holdings | $465.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TRCall | CALL | 46090E903 | $61.5M | 231,000 | 13.2% |
| Invesco QQQ TRPut | PUT | 46090E953 | $55.9M | 210,000 | 12.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $27.1M | 400,060 | 5.8% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $27.1M | 559,515 | 5.8% |
| Teva Pharmaceutical Inds LTDCall | CALL | 881624909 | $20.3M | 2,222,300 | 4.3% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $19.4M | 109,831 | 4.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $18.1M | 710,561 | 3.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $13.4M | 120,600 | 2.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $12.3M | 671,644 | 2.6% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $10.0M | 463,828 | 2.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $9.7M | 60,000 | 2.1% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $9.7M | 71,540 | 2.1% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $9.4M | 25,690 | 2.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $9.2M | 1,305,183 | 2.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $8.5M | 183,696 | 1.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $8.2M | 316,625 | 1.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $7.6M | 158,757 | 1.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.4M | 237,488 | 1.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $7.0M | 469,340 | 1.5% |
| Tower Semiconductor LTDPut | PUT | M87915954 | $7.0M | 161,600 | 1.5% |
| Point Biopharma Global Inc | COM | 730541109 | $6.9M | 952,642 | 1.5% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $6.9M | 558,287 | 1.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $6.8M | 780,852 | 1.5% |
| Cincor Pharma Inc | COM | 17240Y109 | $6.5M | 529,640 | 1.4% |
| Five9 Inc(FIVN) | COM | 338307101 | $6.4M | 95,000 | 1.4% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $6.3M | 380,298 | 1.3% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $5.9M | 1,002,783 | 1.3% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $5.8M | 70,000 | 1.2% |
| Generac Hldgs Inc(GNRC) | COM | 368736104 | $5.0M | 50,000 | 1.1% |
| Merus N V | COM | N5749R100 | $4.9M | 316,993 | 1.1% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $4.6M | 307,283 | 1.0% |
| Leonardo DRS Inc(DRS) | COM | 52661A108 | $4.3M | 335,557 | 0.9% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.2M | 195,591 | 0.9% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.0M | 489,860 | 0.9% |
| Fiverr Intl LTD | NOTE 11/0 | 33835LAA3 | $4.0M | 4,951,000 | 0.9% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.4M | 2,278,845 | 0.7% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $3.3M | 127,200 | 0.7% |
| Apellis Pharmaceuticals IncPut | PUT | 03753U956 | $3.1M | 60,000 | 0.7% |
| Camtek LTD(CAMT) | ORD | M20791105 | $2.4M | 110,000 | 0.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.4M | 1,155,897 | 0.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.3M | 180,600 | 0.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.1M | 7,516 | 0.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.7M | 188,640 | 0.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $1.7M | 1,625,058 | 0.4% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $1.6M | 187,800 | 0.4% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $1.5M | 186,600 | 0.3% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.5M | 200,000 | 0.3% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $1.3M | 626,810 | 0.3% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $1.0M | 75,413 | 0.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $950.0K | 500,000 | 0.2% |